Classification of Antimicrobial Peptides
Antimicrobial peptides (AMPs) are a class of small peptides that widely exist in nature and they are an important part of the innate immune system of different organisms. So far, …
Antimicrobial peptides (AMPs) are a class of small peptides that widely exist in nature and they are an important part of the innate immune system of different organisms. So far, …
What is Peptide Drugs? Peptide is a type of compound formed by connecting multiple amino acids through peptide bonds, usually composed of 10-100 amino acid molecules, and its connection method …
In addition to the traditional chemotherapy, the main methods of treating tumors are usually platinum drugs, alkylating agents, paclitaxel and other cytotoxic molecules. Although these chemotherapeutics can effectively prevent or …
What is a peptide library Peptide library is a group of a large number of several million or more peptides arranged in sequence, that is, the combination of amino acid …
Introduction Alanine scanning library is one of the peptide library design tools. Alanine Scanning Library, this tool allows you to systematically substitute alanine for each amino acid position in your …
Peptide pool is a group of immunostimulatory antigen clusters, which is a collection of a large number of small peptides of specific length and different sequences. It includes the permutation …
Definition of peptide microarrays Peptide microarrays (also commonly called peptide chips or peptide epitope microarrays) are designed based on protein-protein interactions, and a known protein array is immobilized on a …
Recently, Oncopeptides announced that the FDA has accelerated the approval of its research product Pepaxto (melphalan flufenamide, also known as melflufen) to be marketed in combination with dexamethasone for the …
The molecular weight of peptide drugs is between small molecule drugs (<500 Da) and biological products (>5000 Da). The FDA defines peptidesĀ as polymers composed of less than 40 amino acids …
With the development of life sciences research, more and more rare disease-related targets have become known to people, and therapies spawned by new strategies are no longer limited to conventional …